Effect modifying role of serum calcium on mortality-predictability of PTH and alkaline phosphatase in hemodialysis patients: An investigation using data from the Taiwan renal registry data system from 2005 to 2012
作者： Yen-Chung Lin , Yi-Chun Lin , Chiao-Ying Hsu , Chih-Chin Kao , Fan-Chi Chang
DOI: 10.1371/JOURNAL.PONE.0129737
关键词:
摘要: … PD as their initial renal replacement therapy (RRT) modality between 2005 and 2012 (Fig 1)… coverage provided by the NHI policy for all RRT expenditure. Most of the hospitals in Taiwan …
harvard.edu
elsevier.com
paperity.org参考文章(35)
Mariano Rodríguez, Arnold J. Felsenfeld, Barton S. Levine, Serum calcium and bone: effect of PTH, phosphate, vitamin D and uremia. Nefrologia. ,vol. 34, pp. 658- 669 ,(2014) , 10.3265/NEFROLOGIA.PRE2014.JUN.12379
Jaime L Natoli, Rob Boer, Brian H Nathanson, Ross M Miller, Silvia Chiroli, William G Goodman, Vasily Belozeroff, Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis BMC Nephrology. ,vol. 14, pp. 88- 88 ,(2013) , 10.1186/1471-2369-14-88
FC Barreto, DV Barreto, RMA Moysés, KR Neves, MEF Canziani, SA Draibe, V Jorgetti, AB Carvalho, None, K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney International. ,vol. 73, pp. 771- 777 ,(2008) , 10.1038/SJ.KI.5002769
Navdeep Tangri, Martin Wagner, John L. Griffith, Dana C. Miskulin, Alexandra Hodsman, David Ansell, David M.J. Naimark, Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. American Journal of Kidney Diseases. ,vol. 57, pp. 415- 421 ,(2011) , 10.1053/J.AJKD.2010.08.037
Elani Streja, Hsin-Yi Wang, Wei Ling Lau, Miklos Z. Molnar, Csaba P. Kovesdy, Kamyar Kalantar-Zadeh, Jongha Park, Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients Bone. ,vol. 61, pp. 201- 207 ,(2014) , 10.1016/J.BONE.2014.01.016
Molly A Mason, Brian M Shepler, Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis. Pharmacotherapy. ,vol. 30, pp. 741- 748 ,(2010) , 10.1592/PHCO.30.7.741
Chenglong Zhang, Ji Wen, Zi Li, Junming Fan, Efficacy and safety of lanthanum carbonate on chronic kidney disease-mineral and bone disorder in dialysis patients: a systematic review. BMC Nephrology. ,vol. 14, pp. 226- 226 ,(2013) , 10.1186/1471-2369-14-226
Wei Ling Lau, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy, Rajnish Mehrotra, Alkaline phosphatase: Better than PTH as a marker of cardiovascular and bone disease? Hemodialysis International. ,vol. 18, pp. 720- 724 ,(2014) , 10.1111/HDI.12190
Suetonia C Palmer, Andrew Hayen, Petra Macaskill, Fabio Pellegrini, Jonathan C Craig, Grahame J Elder, Giovanni FM Strippoli, Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease: A Systematic Review and Meta-analysis JAMA. ,vol. 305, pp. 1119- 1127 ,(2011) , 10.1001/JAMA.2011.308
Masaaki Inaba, Kiyoshi Nakatsuka, Yasuo Imanishi, Masakazu Watanabe, Yuji Mamiya, Eiji Ishimura, Yoshiki Nishizawa, Technical and Clinical Characterization of the Bio-PTH (1–84) Immunochemiluminometric Assay and Comparison with a Second-Generation Assay for Parathyroid Hormone Clinical Chemistry. ,vol. 50, pp. 385- 390 ,(2004) , 10.1373/CLINCHEM.2003.026831